A 2-month investment opportunity has been introduced to accelerate the delivery of Covid-19 vaccines to 92 low and middle-income economies through Gavi COVAX Advance Market Commitment (AMC).
The US government already has contributed an initial of $2 billion to Gavi in support of COVAX and will contribute an additional $2 billion through 2022, according to the US Department of State.
The US and Gavi Alliance on Thursday applauded new partner commitments to accelerate global access to Covid-19 vaccines, including more than $300 million in financial contributions and millions of safe and effective COVID-19 vaccine doses to be shared by COVAX.
The US recognizes that as long as Covid-19 is spreading and generating new variants anywhere, it poses a threat to people everywhere.
At an event hosted by the US and Gavi, US Secretary of State Antony J Blinken and USAID Acting Administrator Gloria Steele applauded other countries who made and delivered pledges and urged all partners to do more to end the pandemic.
Secretary Blinken expressed that, apart from that pledged $4 billion, the US is prepared to provide further assistance to support the global Covid response.
He called on partners to work side by side with Gavi to support urgent vaccine manufacturing, supply, and delivery needs
COVAX is an initiative co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI), UNICEF and the World Health Organization (WHO), with an aim to equitably deliver safe and effective Covid-19 vaccines on a global scale.
